Research Article

The Pancreatic Hypermetabolic Lesions of Lung Carcinoma Patients in F-18-Fluorodeoxyglucose PET-CT: Correlation with Pathology

Volume: 4 Number: 3 January 14, 2025
EN

The Pancreatic Hypermetabolic Lesions of Lung Carcinoma Patients in F-18-Fluorodeoxyglucose PET-CT: Correlation with Pathology

Abstract

Aim: The ratio and results of the hypermetabolic lesions of the pancreas in lung carcinoma patients in FDG PET-CT which is rare, wasn’t sufficiently evaluated previously in the literature. The aim of this study was to determine these lesions’ pathologic correlations. Materials and Methods: The F-18 FDG PET/CT images of the 516 patients with Lung Carcinoma was evaluated retrospectively by an Experienced Nuclear Medicine Physician and correlation of Pathology results were analyzed. Results: The ratio of the pancreatic hypermetabolic lesions were 7% (36 patients). Pathology results revealed small cell lung carcinoma metastasis in 23, adenocarcinoma in 8, squamous cell carcinoma in 1 and atypical carcinoid tumor in 1 and other pathology types in rest of the patients in primary Lung Carcinoma. Five of the pancreatic lesions pathology results could be obtained and three were small cell lung carcinoma, one of them was adenocarcinoma and the squamous cell carcinoma in other one. Conclusion: The hypermetabolic pancreatic lesions in Lung Carcinoma patients in F-18 FDG PET/CT should be evaluated and considered carefully. Since unexpected pathology results could be achieved.

Keywords

References

  1. Sato, M., Okumura, T., Kaito, K., Kiyoshima, M., Asato, Y., Uchiumi, K., Iijima, H., Hashimoto, I., Kaburagi, T., & Amemiya, R. (2009). Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer. Annals of nuclear medicine, 23(1), 49–57. https://doi.org/10.1007/s12149-008-0205-5
  2. García Vidal, C., Carrillo, E., & Barreiro, B. (2003). Metástasis pancreática solitaria en paciente con neoplasia de pulmón [Solitary metastasis to the pancreas in a patient with lung cancer]. Archivos de bronconeumologia, 39(12), 601. https://doi.org/10.1016/s0300-2896(03)75458-1
  3. Liratzopoulos, N., Efremidou, E. I., Papageorgiou, M. S., Romanidis, K., Minopoulos, G. J., & Manolas, K. J. (2006). Extrahepatic biliary obstruction due to a solitary pancreatic metastasis of squamous cell lung carcinoma. Case report. Journal of gastrointestinal and liver diseases : JGLD, 15(1), 73–75.
  4. Wang, W., Kan, Y., Yang, X., Liu, J., & Yang, J. (2019). Concurrent Pancreatic Metastasis From Lung Adenocarcinoma and Primary Cholangiocarcinoma on FDG PET/CT Imaging. Clinical nuclear medicine, 44(5), 426–428. https://doi.org/10.1097/RLU.0000000000002496
  5. Zhou, W., Dong, H., & Dong, A. (2020). Isolated Pancreatic Metastasis From Squamous Cell Lung Cancer Mimicking Primary Pancreatic Ductal Adenocarcinoma on FDG PET/CT. Clinical nuclear medicine, 45(5), 420–422. https://doi.org/10.1097/RLU.0000000000002986

Details

Primary Language

English

Subjects

Clinical Oncology, Nuclear Medicine

Journal Section

Research Article

Publication Date

January 14, 2025

Submission Date

November 28, 2024

Acceptance Date

December 30, 2024

Published in Issue

Year 2024 Volume: 4 Number: 3

APA
Yavan, G., Koç, Z. P., Özcan, P. P., Eser, K., & Yaldız, M. (2025). The Pancreatic Hypermetabolic Lesions of Lung Carcinoma Patients in F-18-Fluorodeoxyglucose PET-CT: Correlation with Pathology. Molecular Oncologic Imaging, 4(3), 13-17. https://doi.org/10.71286/moi.1592953
AMA
1.Yavan G, Koç ZP, Özcan PP, Eser K, Yaldız M. The Pancreatic Hypermetabolic Lesions of Lung Carcinoma Patients in F-18-Fluorodeoxyglucose PET-CT: Correlation with Pathology. Molecular Oncologic Imaging. 2025;4(3):13-17. doi:10.71286/moi.1592953
Chicago
Yavan, Gökçe, Zehra Pınar Koç, Pınar Pelin Özcan, Kadir Eser, and Mehmet Yaldız. 2025. “The Pancreatic Hypermetabolic Lesions of Lung Carcinoma Patients in F-18-Fluorodeoxyglucose PET-CT: Correlation With Pathology”. Molecular Oncologic Imaging 4 (3): 13-17. https://doi.org/10.71286/moi.1592953.
EndNote
Yavan G, Koç ZP, Özcan PP, Eser K, Yaldız M (January 1, 2025) The Pancreatic Hypermetabolic Lesions of Lung Carcinoma Patients in F-18-Fluorodeoxyglucose PET-CT: Correlation with Pathology. Molecular Oncologic Imaging 4 3 13–17.
IEEE
[1]G. Yavan, Z. P. Koç, P. P. Özcan, K. Eser, and M. Yaldız, “The Pancreatic Hypermetabolic Lesions of Lung Carcinoma Patients in F-18-Fluorodeoxyglucose PET-CT: Correlation with Pathology”, Molecular Oncologic Imaging, vol. 4, no. 3, pp. 13–17, Jan. 2025, doi: 10.71286/moi.1592953.
ISNAD
Yavan, Gökçe - Koç, Zehra Pınar - Özcan, Pınar Pelin - Eser, Kadir - Yaldız, Mehmet. “The Pancreatic Hypermetabolic Lesions of Lung Carcinoma Patients in F-18-Fluorodeoxyglucose PET-CT: Correlation With Pathology”. Molecular Oncologic Imaging 4/3 (January 1, 2025): 13-17. https://doi.org/10.71286/moi.1592953.
JAMA
1.Yavan G, Koç ZP, Özcan PP, Eser K, Yaldız M. The Pancreatic Hypermetabolic Lesions of Lung Carcinoma Patients in F-18-Fluorodeoxyglucose PET-CT: Correlation with Pathology. Molecular Oncologic Imaging. 2025;4:13–17.
MLA
Yavan, Gökçe, et al. “The Pancreatic Hypermetabolic Lesions of Lung Carcinoma Patients in F-18-Fluorodeoxyglucose PET-CT: Correlation With Pathology”. Molecular Oncologic Imaging, vol. 4, no. 3, Jan. 2025, pp. 13-17, doi:10.71286/moi.1592953.
Vancouver
1.Gökçe Yavan, Zehra Pınar Koç, Pınar Pelin Özcan, Kadir Eser, Mehmet Yaldız. The Pancreatic Hypermetabolic Lesions of Lung Carcinoma Patients in F-18-Fluorodeoxyglucose PET-CT: Correlation with Pathology. Molecular Oncologic Imaging. 2025 Jan. 1;4(3):13-7. doi:10.71286/moi.1592953